Published in Cancer Res on March 01, 1986
Transcriptional activation of the human epidermal growth factor receptor promoter by human p53. Mol Cell Biol (1996) 1.37
A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res (2008) 1.27
Animal models of human response to dioxins. Environ Health Perspect (1998) 1.05
In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore. Neoplasia (2010) 1.04
Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer. Proc Natl Acad Sci U S A (1987) 1.04
Transcripts for transforming growth factors in human breast cancer: clinical correlates. Br J Cancer (1990) 1.02
An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers. Br J Cancer (1990) 1.02
Bipartite inhibition of Drosophila epidermal growth factor receptor by the extracellular and transmembrane domains of Kekkon1. Genetics (2004) 0.99
Angiogenic growth factors in neural embryogenesis and neoplasia. Am J Pathol (1995) 0.96
Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signaling. J Cancer Res Clin Oncol (2008) 0.95
Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast. Br J Cancer (1989) 0.94
Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer. Br J Cancer (1992) 0.92
Epidermal growth factor-urogastrone causes vasodilatation in the anesthetized dog. J Clin Invest (1987) 0.92
Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines. Acta Neuropathol (1988) 0.87
Epidermal growth factor receptors in idiopathic and virally induced skin diseases. Am J Pathol (1992) 0.87
Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin. Arch Dermatol Res (1989) 0.85
Epidermal growth factor receptor is increased in multidrug-resistant Chinese hamster and mouse tumor cells. Proc Natl Acad Sci U S A (1986) 0.85
Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis. Genet Test Mol Biomarkers (2012) 0.84
Augmentation of chemically induced pancreatic and bronchial cancers by epidermal growth factor. Gut (1987) 0.84
A preliminary study of the safety of red light phototherapy of tissues harboring cancer. Photomed Laser Surg (2012) 0.83
Relationship between epidermal growth factor and dehydroepiandrosterone and its sulphate in breast cyst fluid. Br J Cancer (1989) 0.83
Expression of neu protein, epidermal growth factor receptor, and transforming growth factor alpha in breast cancer. Correlation with clinicopathologic parameters. Am J Pathol (1991) 0.82
Urinary epidermal growth factor concentrations in various human malignancies. Br J Cancer (1988) 0.81
Functional epidermal growth factor gene polymorphisms and risk of gastric cancer. Oncol Lett (2012) 0.81
Heparin-binding EGF-like growth factor enhances the activity of invasion and metastasis in thyroid cancer cells. Oncol Rep (2013) 0.81
A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patients. Onco Targets Ther (2013) 0.80
Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies. BMC Cancer (2015) 0.78
The effects of continuous exposure to epidermal growth factor on the spontaneous transformation of cultured rat liver epithelial cells. Am J Pathol (1992) 0.77
[Molecular diagnostics in lung carcinoma for therapy stratification]. Pathologe (2010) 0.77
Association between the epidermal growth factor +61 G/A polymorphism and glioma risk: a meta-analysis. PLoS One (2014) 0.77
Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma. Am J Cancer Res (2014) 0.77
EGFR/erB-1, HER2/erB-2, CK7, LP34, Ki67 and P53 expression in preneoplastic lesions of bronchial epithelium: an immunohistochemical and genetic study. Virchows Arch (2011) 0.77
Persistent expression of mitogenic/transforming factors at the site of failed orthopaedic implants: the impact on immune reactivity. J Mater Sci Mater Med (1998) 0.76
Coronavirus infections in the laboratory rat: degree of cross protection following immunization with a heterologous strain. Can J Vet Res (1994) 0.75
Quantitation of protein. Methods Enzymol (1990) 5.00
Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry (1992) 2.30
Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J Clin Invest (2000) 2.21
Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts. J Cell Biol (1984) 2.12
Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol (1994) 1.78
The visualization of human erythrocyte membrane proteins and glycoproteins in SDS polyacrylamide gels employing a single staining procedure. Anal Biochem (1976) 1.72
Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med (1987) 1.66
Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif (1991) 1.60
Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol (1986) 1.56
Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol (1992) 1.48
Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor. Proc Natl Acad Sci U S A (1983) 1.48
Mercury exposure and cutaneous disease. J Am Acad Dermatol (2000) 1.47
Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol (1998) 1.46
The dynamic link between the integrity of the immune system and zinc status. J Nutr (2000) 1.45
The North American experience with photopheresis. Ther Apher (1999) 1.42
Transgenic mice as a model to study the role of TGF-beta-related molecules in hair follicles. Genes Dev (1993) 1.40
An evaluation of the accuracy of residency applicants' curricula vitae: are the claims of publications erroneous? J Am Acad Dermatol (1996) 1.40
Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods (1994) 1.36
Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ (1993) 1.33
Primary follicular dystrophy with scarring dermatitis in C57BL/6 mouse substrains resembles central centrifugal cicatricial alopecia in humans. Vet Pathol (2010) 1.32
Characterization by electrophoresis of epidermal growth factor stimulated phosphorylation using A-431 membranes. Biochemistry (1980) 1.31
What is the 'true' function of skin? Exp Dermatol (2002) 1.26
Management of alopecia areata. BMJ (2010) 1.25
Immunolocalization of epidermal growth factor receptors in normal developing human skin. J Invest Dermatol (1990) 1.23
Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp. A case report and review of secondary squamous cell carcinomas. J Am Acad Dermatol (1981) 1.21
Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer. Methods Cell Biol (1995) 1.21
Identification of the substance binding pemphigus antibody and concanavalin A in the skin. J Invest Dermatol (1974) 1.20
Chronic elevation of plasma corticosterone causes reductions in the number of cycling cells of the B lineage in murine bone marrow and induces apoptosis. Immunology (1993) 1.17
Characteristics of antibodies to the epidermal growth factor receptor-kinase. Arch Biochem Biophys (1983) 1.16
What causes alopecia areata? Exp Dermatol (2013) 1.14
Comparison of alopecia areata in human and nonhuman mammalian species. Pathobiology (1998) 1.14
Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J Invest Dermatol (1984) 1.14
Necrotic arachnidism. J Am Acad Dermatol (2001) 1.13
Nineteen documented cases of Loxosceles reclusa envenomation. J Am Acad Dermatol (2001) 1.12
Mouse mutations as animal models and biomedical tools for dermatological research. J Invest Dermatol (1996) 1.12
Calcium effects on human erythrocyte membrane proteins. Biochim Biophys Acta (1977) 1.07
The psychogeriatric nurse in home health care: use of research to develop the role. Clin Nurse Spec (1996) 1.07
Quantitative determination of EGF-R during epidermal wound healing. J Invest Dermatol (1992) 1.06
Functional and structural characteristics of EGF and its receptor and their relationship to transforming proteins. J Cell Biochem (1986) 1.06
The EGF/TGF alpha receptor in skin. J Invest Dermatol (1990) 1.06
Protein assay sensitive at nanogram levels. Anal Biochem (1987) 1.05
Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis. Arthritis Res Ther (2006) 1.04
Characterization of the metabolic turnover of epidermal growth factor receptor protein in A-431 cells. J Cell Physiol (1984) 1.04
Erythroderma: review of 82 cases. South Med J (1986) 1.03
Glucocorticoids and irradiation-induced apoptosis in normal murine bone marrow B-lineage lymphocytes as determined by flow cytometry. Immunology (1993) 1.02
Spontaneous alopecia areata-like hair loss in one congenic and seven inbred laboratory mouse strains. J Investig Dermatol Symp Proc (1999) 1.02
Dapsone treatment of a brown recluse bite. JAMA (1983) 1.02
Epidermal growth factor/transforming growth factor alpha receptors and psoriasis. J Invest Dermatol (1990) 1.01
Alopecia areata: an autoimmune disease? Exp Dermatol (1999) 1.01
Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-beta related transgene. Teratog Carcinog Mutagen (1995) 1.01
Reactive site-dependent phenotypic alterations in plasminogen activator inhibitor-1 transgenic mice. J Thromb Haemost (2007) 1.01
Studies of the biological activity of insulin, cyclic nucleotides and concanavalin A in the isolated fat cell. Horm Metab Res (1975) 1.00
Feasibility study on the spatial and temporal movement of Samburu's cattle and wildlife in Kenya using GPS radio-tracking, remote sensing and GIS. Prev Vet Med (2013) 1.00
Localization of immunoreactive epidermal growth factor receptors in human nervous system. J Histochem Cytochem (1988) 0.98
Biology of the A-431 cell: a useful organism for hormone research. J Cell Biochem (1983) 0.98
Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture. Cell Growth Differ (1994) 0.98
Brown recluse spider bites. A comparison of early surgical excision versus dapsone and delayed surgical excision. Ann Surg (1985) 0.96
Visualization of epidermal growth factor receptors in human epidermis. J Invest Dermatol (1984) 0.96
Erythroderma. Who, where, when, why, and how ... Arch Dermatol (1994) 0.96
Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topical EGF. J Invest Dermatol (1992) 0.95
Lanceolate hair-J (lahJ): a mouse model for human hair disorders. Exp Dermatol (2000) 0.95
Cutaneous manifestations of Prototheca infections. J Am Acad Dermatol (1995) 0.94
Disulfiram-alcohol skin reaction to beer-containing shampoo. JAMA (1980) 0.94
The diagnosis and treatment of brown recluse spider bites. Ann Emerg Med (1987) 0.93
Spiders and spider bites. Dermatol Clin (1990) 0.91
The EGF receptor-kinase has multiple phosphorylation sites. Biochem Biophys Res Commun (1982) 0.91
Epidermal growth factor and its receptor in the developing human nervous system. Brain Res Dev Brain Res (1991) 0.90
Different forms of the epidermal growth factor receptor kinase have different autophosphorylation sites. Biochemistry (1985) 0.90
A rapid fluorometric method for the estimation of DNA in cultured cells. Anal Biochem (1981) 0.90
Muscle abnormalities in scleroderma. Rheum Dis Clin North Am (1996) 0.88
Basal cell carcinoma with ossification. J Am Acad Dermatol (1998) 0.88
Biosynthesis of the epidermal growth factor receptor in cultured human cells. Endocrinology (1985) 0.88
Molecular aspects of the cell cycle and encystment of Acanthamoeba. Rev Infect Dis (1991) 0.88
Colchicine in dermatology. J Am Acad Dermatol (1998) 0.88
Calcium facilitates endogenous proteolysis of the EGF receptor-kinase. Mol Cell Endocrinol (1982) 0.88
Alopecia areata in humans and other mammalian species. J Invest Dermatol (1995) 0.88
Brown recluse spider bites: stay cool. JAMA (1985) 0.87
Epidermal growth factor receptors in idiopathic and virally induced skin diseases. Am J Pathol (1992) 0.87
Melanocyte and gonad activity as potential severity modifying factors in C3H/HeJ mouse alopecia areata. Exp Dermatol (2001) 0.87
Immunoreactive epidermal growth factor receptors in neuritic plaques from patients with Alzheimer's disease. J Neuropathol Exp Neurol (1988) 0.87
Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration. Osteoarthritis Cartilage (2004) 0.86
Criteria for the diagnosis of staphylococcal scalded skin syndrome in adults. Cutis (1983) 0.86
Possible roles for glucocorticoids and apoptosis in the suppression of lymphopoiesis during zinc deficiency: a review. J Am Coll Nutr (1995) 0.86
A distinct role for apoptosis in the changes in lymphopoiesis and myelopoiesis created by deficiencies in zinc. FASEB J (2001) 0.85
Androgenetic alopecia: in vivo models. Exp Mol Pathol (1999) 0.85
Interaction of brown recluse spider venom on cell membranes: the inciting mechanism? J Invest Dermatol (1984) 0.85
Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process. Hematol Oncol (1990) 0.84
Animal models for male pattern (androgenetic) alopecia. Eur J Dermatol (2001) 0.84
Morphology of hair in normal and mutant laboratory mice. Eur J Dermatol (2001) 0.84
Palmar-plantar erythrodysesthesia and cytarabine. Ann Intern Med (1985) 0.84
Erythroderma and exfoliative dermatitis. Clin Dermatol (1993) 0.84
What does epidermal growth factor do and how does it do it? J Invest Dermatol (1985) 0.84
Brown recluse spider bites of the upper extremity. South Med J (1988) 0.84
The sign of Leser-Trélat. Report of a case with adenocarcinoma of the duodenum. Arch Dermatol (1980) 0.84